Licenses tumor-activated prodrug technology, for development of small molecule anticancer agents, to optimise potency and toxicity. Manufacturing in Norwood, and headquarters in Cambridge, Massachusetts. (Nasdaq: IMGN)

Visits
288
Added
Jul 1, 2023
Rating
(119)
Rate This Site
QR Code
QR code Download PNG
Embed Badge
Place this code on your website to show you're listed here.
Advertise herefrom $15.00/day  ·  RON $21.00/day
Get the best links delivered weekly — hand-picked from 1,200,429 resources